Aldosterone Receptor Antagonists Effective but Often Forgotten

被引:74
作者
Maron, Bradley A. [1 ]
Leopold, Jane A.
机构
[1] Brigham & Womens Hosp, Div Cardiovasc Med, Boston, MA 02115 USA
关键词
heart failure; hypertension; obesity; pharmacokinetics; pharmacology; CHRONIC HEART-FAILURE; VENTRICULAR SYSTOLIC DYSFUNCTION; ACUTE MYOCARDIAL-INFARCTION; RESISTANT HYPERTENSION; LONG-TERM; PLASMA-ALDOSTERONE; SERUM ALDOSTERONE; EPLERENONE; SPIRONOLACTONE; EFFICACY;
D O I
10.1161/CIRCULATIONAHA.109.895235
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:934 / 939
页数:6
相关论文
共 38 条
[1]  
ALBERT NM, 2009, JAMA-J AM MED ASSOC, V21, P1658
[2]   Aldosterone and long-term outcome after myocardial infarction: A substudy of the French nationwide Observatory for hospital care, the Development in one year and the characteristics of patients presenting with myocardial infarction with or without Q wave (OPERA) study [J].
Beygui, Farzin ;
Montalescot, Gilles ;
Vicaut, Eric ;
Rouanet, Stephanie ;
Van Belle, Eric ;
Baulac, Cathrine ;
Degrandsart, Alexia ;
Dallongeville, Jean .
AMERICAN HEART JOURNAL, 2009, 157 (04) :680-687
[3]   Anti-remodelling effect of canrenone in patients with mild chronic heart failure (AREA IN-CHF study): final results [J].
Boccanelli, Alessandro ;
Mureddu, Gian Francesco ;
Cacciatore, Giuseppe ;
Clemenza, Francesco ;
Di Lenarda, Andrea ;
Gavazzi, Antonello ;
Porcus, Maurizio ;
Latini, Roberto ;
Lucci, Donata ;
Maggioni, Aldo Pietro ;
Masson, Serge ;
Vanasia, Massimo ;
de Simone, Giovanni .
EUROPEAN JOURNAL OF HEART FAILURE, 2009, 11 (01) :68-76
[4]   Hyperaldosteronism among with resistant black and white subjects hypertension [J].
Calhoun, DA ;
Nishizaka, MK ;
Zaman, MA ;
Thakkar, RB ;
Weissmann, P .
HYPERTENSION, 2002, 40 (06) :892-896
[5]   Long-term cardiac effects of adrenalectomy or mineralocorticoid antagonists in patients with primary aldosteronism [J].
Catena, Cristiana ;
Colussi, GianLuca ;
Lapenna, Roberta ;
Nadalini, Elisa ;
Chiuch, Alessandra ;
Gianfagna, Pasquale ;
Sechi, Leonardo A. .
HYPERTENSION, 2007, 50 (05) :911-918
[6]   Effect of spironolactone on blood pressure in subjects with resistant hypertension [J].
Chapman, Neil ;
Dobson, Joanna ;
Wilson, Sarah ;
Dahlof, Bjorn ;
Sever, Peter S. ;
Wedel, Hans ;
Poulter, Neil R. .
HYPERTENSION, 2007, 49 (04) :839-845
[7]   Long-term, dose-dependent effects of spironolactone on left ventricular function and exercise tolerance in patients with chronic heart failure [J].
Cicoira, M ;
Zanolla, L ;
Rossi, A ;
Golia, G ;
Franceschini, L ;
Brighetti, G ;
Marino, P ;
Zardini, P .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 40 (02) :304-310
[8]   Aldosterone blockade and left ventricular dysfunction: a systematic review of randomized clinical trials [J].
Ezekowitz, Justin A. ;
McAlister, Finlay A. .
EUROPEAN HEART JOURNAL, 2009, 30 (04) :469-477
[9]   Efficacy and tolerability of eplerenone and losartan in hypertensive of eplerenone and black and white patients [J].
Flack, JM ;
Oparil, S ;
Pratt, JH ;
Roniker, B ;
Garthwaite, S ;
Kleiman, JH ;
Yang, YH ;
Krause, SL ;
Workman, D ;
Saunders, E .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (07) :1148-1155
[10]   Cross-sectional relations of serum aldosterone and urine sodium excretion to urinary albumin excretion in a community-based sample [J].
Fox, C. S. ;
Larson, M. G. ;
Hwang, S-J ;
Leip, E. P. ;
Rifai, N. ;
Levy, D. ;
Benjamin, E. J. ;
Murabito, J. M. ;
Meigs, J. B. ;
Vasan, R. S. .
KIDNEY INTERNATIONAL, 2006, 69 (11) :2064-2069